A lifespan observation of a novel mouse model: In vivo evidence supports Aβ oligomer hypothesis

Yichi Zhang, Lu Lu, Jianping Jia, Longfei Jia, Changiz Geula, Jinjing Pei, Zhiqing Xu, Wei Qin, Ruiqin Liu, Dan Li, Na Pan

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


Transgenic mouse models are powerful tools in exploring the mechanisms of AD. Most current transgenic models of AD mimic the memory impairment and the main pathologic features, among which the formation of beta-amyloid (Aβ) plaques is considered a dominant pathologic event. Recently, Aβ oligomers have been identified as more neurotoxic than Aβ plaques. However, no ideal transgenic mouse model directly support Ab oligomers as a neurotoxic species due to the puzzling effects of amyloid plaques in the more widely-used models. Here, we constructed a single-mutant transgenic (Tg) model harboring the PS1V97L mutation and used Non-Tg littermates as a control group. Employing the Morris water maze, electrophysiology, immunohistochemistry, biochemistry, and electron microscopy, we investigated behavioral changes and pathology progression in our single-mutant transgenic model. We discovered the pathological alteration of intraneuronal accumulation of Aβ oligomers without Aβ plaques in the PS1V97L-Tg mouse model, which might be the result of PS1 gene mutation. Following Aβ oligomers, we detected synaptic alteration, tau hyperphosphorylation and glial activation. This model supports an initial role for Aβ oligomers in the onset of AD and suggests that Aβ plaques may not be the only prerequisite. This model provides a useful tool for studying the role of Aβ oligomers in AD pathogenesis.

Original languageEnglish (US)
Article numbere85885
JournalPloS one
Issue number1
StatePublished - Jan 21 2014

ASJC Scopus subject areas

  • General


Dive into the research topics of 'A lifespan observation of a novel mouse model: In vivo evidence supports Aβ oligomer hypothesis'. Together they form a unique fingerprint.

Cite this